These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1541559)

  • 1. Growth inhibition of Candida albicans by interleukin-2-activated splenocytes.
    Beno DW; Mathews HL
    Infect Immun; 1992 Mar; 60(3):853-63. PubMed ID: 1541559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes.
    Beno DW; Stöver AG; Mathews HL
    J Immunol; 1995 May; 154(10):5273-81. PubMed ID: 7730631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of interleukin-2-activated natural killer (NK1.1+) lymphocytes against Candida albicans.
    Mathews HL; Witek-Janusek L
    J Med Microbiol; 1998 Nov; 47(11):1007-14. PubMed ID: 9822300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of Candida albicans by interleukin-2-induced lymph node cells.
    Beno DW; Mathews HL
    Cell Immunol; 1990 Jun; 128(1):89-100. PubMed ID: 2188739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C. albicans hyphae in vitro.
    Scaringi L; Blasi E; Rosati E; Marconi P; Bistoni F
    J Gen Microbiol; 1991 Dec; 137(12):2851-6. PubMed ID: 1791439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans.
    Scaringi L; Cornacchione P; Rosati E; Boccanera M; Cassone A; Bistoni F; Marconi P
    Cell Immunol; 1990 Sep; 129(2):271-87. PubMed ID: 2166624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor.
    Djeu JY; Blanchard DK
    J Immunol; 1987 Oct; 139(8):2761-7. PubMed ID: 2443572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity inhibition of cytolytic lymphocytes by omeprazole.
    Scaringi L; Cornacchione P; Fettucciari K; Rosati E; Rossi R; Marconi P; Capodicasa E
    Scand J Immunol; 1996 Sep; 44(3):204-14. PubMed ID: 8795713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans.
    Levitz SM; North EA
    Infect Immun; 1996 May; 64(5):1595-9. PubMed ID: 8613366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of killer cells stimulated with both interleukin-2 and interleukin-12 on mouse glioma cells.
    Kikuchi T; Joki T; Abe T; Ohno T
    J Immunother; 1999 May; 22(3):245-50. PubMed ID: 10335484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the functional activity of IL-2-activated lymphocytes by CGRP.
    Wang X; Fiscus RR; Yang L; Mathews HL
    Cell Immunol; 1995 Apr; 162(1):105-13. PubMed ID: 7704898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro.
    Gülay Z; Imir T
    Immunobiology; 1996 Jul; 195(2):220-30. PubMed ID: 8877398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.
    Wei S; Serbousek D; McMillen S; Blanchard DK; Djeu JY
    J Immunol; 1991 Jan; 146(1):337-42. PubMed ID: 1898605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK; Leland P
    Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine-activated killer cell regulation of T-cell-mediated immunity to Candida albicans.
    Wei S; Blanchard DK; McMillen S; Djeu JY
    Infect Immun; 1992 Sep; 60(9):3586-95. PubMed ID: 1500166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes.
    Yamamoto H; Hirayama M; Genyea C; Kaplan J
    J Immunol; 1994 Apr; 152(8):3842-7. PubMed ID: 8144953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice.
    Radzikowski C; Rygaard J; Budzynski W; Stenvang JP; Schou M; Vangsted A; Zeuthen J
    APMIS; 1994 Jul; 102(7):481-8. PubMed ID: 7917216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.